FSD Pharma Other Current Liabilities

FSD Pharma (HUGE) currently reports a other current liabilities of $820K as of June 2024. That compares with $120K in the prior-year period — up 567.4% year over year. Use the charts on this page to explore FSD Pharma's other current liabilities history and peer comparisons.

FSD Pharma's other current liabilities increased from $120K to $820K — a 567.4% year-over-year increase (period ending June 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

FSD Pharma reported $820K in other current liabilities as of June 2024. That compares with $120K in the prior-year period — up 567.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $820K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for FSD Pharma, and consider following HUGE for alerts when major investors trade the stock.

FSD Pharma is classified in the Healthcare sector. On other current liabilities, it currently shows $820K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing HUGE with unrelated industries.